WaferGen SmartChip System to be Used in Wound Drug Research | GenomeWeb

NEW YORK (GenomeWeb News) – WaferGen Biosystems said today that its SmartChip Real-Time PCR System will be used in preclinical and clinical studies of ImmuneRegen's wound-healing drug candidate Homspera.

The studies will be carried out by researchers at the University of Texas Southwestern Medical Center. They will use the SmartChip system to validate relevant gene expression biomarkers and to assess their impact on patient response to treatment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.